Cargando…
Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study
To investigate the prevalence of, and risk factors for, cervical infection with human papillomavirus (HPV) in Shenyang City, People's Republic of China, we interviewed and obtained cervical cell samples from 685 women aged 15–59 years enumerated from local population lists. Human papillomavirus...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360733/ https://www.ncbi.nlm.nih.gov/pubmed/17088908 http://dx.doi.org/10.1038/sj.bjc.6603450 |
_version_ | 1782153121977335808 |
---|---|
author | Li, L K Dai, M Clifford, G M Yao, W Q Arslan, A Li, N Shi, J F Snijders, P J F Meijer, C J L M Qiao, Y L Franceschi, S |
author_facet | Li, L K Dai, M Clifford, G M Yao, W Q Arslan, A Li, N Shi, J F Snijders, P J F Meijer, C J L M Qiao, Y L Franceschi, S |
author_sort | Li, L K |
collection | PubMed |
description | To investigate the prevalence of, and risk factors for, cervical infection with human papillomavirus (HPV) in Shenyang City, People's Republic of China, we interviewed and obtained cervical cell samples from 685 women aged 15–59 years enumerated from local population lists. Human papillomavirus DNA was detected in cervical cell samples using a GP5+/6+-based PCR assay for 44 HPV types. Human papillomavirus prevalence was 16.8% overall and 13.6% among women without cervical abnormalities (16.6% and 12.4%, respectively, age-standardised to the world standard population), with no significant trends in HPV prevalence by age group. Of the 32 types identified, high-risk HPV types predominated in all age groups, HPV16 being the most common (3.4% of all women), followed by HPV52 (2.5%) and 58 (1.9%). Multiple-type infections accounted for 31.3% of all infected women. Not being married, reporting multiple sexual partners and husband's extramarital sexual relationships were all significantly associated with being HPV-positive. The disclosure of a relatively high HPV prevalence in Shenyang, in comparison with other worldwide populations, raises important questions concerning the prevention of cervical cancer in China, especially given the promising efficacy of prophylactic HPV vaccines. |
format | Text |
id | pubmed-2360733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23607332009-09-10 Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study Li, L K Dai, M Clifford, G M Yao, W Q Arslan, A Li, N Shi, J F Snijders, P J F Meijer, C J L M Qiao, Y L Franceschi, S Br J Cancer Epidemiology To investigate the prevalence of, and risk factors for, cervical infection with human papillomavirus (HPV) in Shenyang City, People's Republic of China, we interviewed and obtained cervical cell samples from 685 women aged 15–59 years enumerated from local population lists. Human papillomavirus DNA was detected in cervical cell samples using a GP5+/6+-based PCR assay for 44 HPV types. Human papillomavirus prevalence was 16.8% overall and 13.6% among women without cervical abnormalities (16.6% and 12.4%, respectively, age-standardised to the world standard population), with no significant trends in HPV prevalence by age group. Of the 32 types identified, high-risk HPV types predominated in all age groups, HPV16 being the most common (3.4% of all women), followed by HPV52 (2.5%) and 58 (1.9%). Multiple-type infections accounted for 31.3% of all infected women. Not being married, reporting multiple sexual partners and husband's extramarital sexual relationships were all significantly associated with being HPV-positive. The disclosure of a relatively high HPV prevalence in Shenyang, in comparison with other worldwide populations, raises important questions concerning the prevention of cervical cancer in China, especially given the promising efficacy of prophylactic HPV vaccines. Nature Publishing Group 2006-12-04 2006-10-31 /pmc/articles/PMC2360733/ /pubmed/17088908 http://dx.doi.org/10.1038/sj.bjc.6603450 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Epidemiology Li, L K Dai, M Clifford, G M Yao, W Q Arslan, A Li, N Shi, J F Snijders, P J F Meijer, C J L M Qiao, Y L Franceschi, S Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study |
title | Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study |
title_full | Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study |
title_fullStr | Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study |
title_full_unstemmed | Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study |
title_short | Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study |
title_sort | human papillomavirus infection in shenyang city, people's republic of china: a population-based study |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360733/ https://www.ncbi.nlm.nih.gov/pubmed/17088908 http://dx.doi.org/10.1038/sj.bjc.6603450 |
work_keys_str_mv | AT lilk humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT daim humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT cliffordgm humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT yaowq humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT arslana humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT lin humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT shijf humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT snijderspjf humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT meijercjlm humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT qiaoyl humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy AT franceschis humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy |